ANNALEE KONNOS: Open Payments
NPI 1245866888 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,699 in 142 payments from 20 companies in 2025. Trend: 2023 $285 · 2024 $118 · 2025 $2,699
Food & beverage: $2,699
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 66 | $908 |
| AstraZeneca Pharmaceuticals LP | 9 | $429 |
| GENZYME CORPORATION | 10 | $296 |
| Verona Pharma, Inc. | 10 | $182 |
| Merck Sharp & Dohme LLC | 9 | $174 |
| Grifols USA, LLC | 10 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Actelion Pharmaceuticals US, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
Products named: NUCALA, DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, WINREVAIR, Prolastin-C Liquid, GLASSIA.
Industry payments across KY — which companies pay providers there.
